Authors’ Reply to Chia Siang Kow et al.: Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?’

Kow CS, Ramachandram DS, Hasan SS. Comment on: ‘Should we interfere with the interleukin-6 receptor during COVID-19: what do we know so far?’ Drugs. 2023. https://doi.org/10.1007/s40265-023-01869-6.

Article  Google Scholar 

Plocque A, Mitri C, Lefèvre C, Tabary O, Touqui L, Philippart F. Should we interfere with the interleukin-6 receptor during COVID-19: what do we know so far? Drugs. 2023;83:1–36.

Article  CAS  PubMed  Google Scholar 

Kang S, Tanaka T, Narazaki M, Kishimoto T. Targeting interleukin-6 signaling in clinic. Immunity. 2019;50:1007–23.

Article  CAS  PubMed  Google Scholar 

Murakami M, Kamimura D, Hirano T. Pleiotropy and specificity: insights from the interleukin 6 family of cytokines. Immunity. 2019;50:812–31.

Article  CAS  PubMed  Google Scholar 

Taniguchi K, Wu L-W, Grivennikov SI, de Jong PR, Lian I, Yu F-X, et al. A gp130-Src-YAP module links inflammation to epithelial regeneration. Nature. 2015;519:57–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840–51.

Article  CAS  PubMed  Google Scholar 

Haussner F, Chakraborty S, Halbgebauer R, Huber-Lang M. Challenge to the intestinal mucosa during sepsis. Front Immunol. 2019;10:891.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent J-L. Sepsis and septic shock. Nat Rev Dis Primers. 2016;2:16045.

Article  PubMed  PubMed Central  Google Scholar 

Damiani I, Corsini A, Bellosta S. Potential statin drug interactions in elderly patients: a review. Expert Opin Drug Metab Toxicol. 2020;16:1133–45.

Article  CAS  PubMed  Google Scholar 

Frigault MJ, Nikiforow S, Mansour MK, Hu Z-H, Horowitz MM, Riches ML, et al. Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19? Blood. 2020;136:137–9.

Article  CAS  PubMed  Google Scholar 

Bersanelli M. Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors. Immunother Future Med. 2020;12:269–73.

Article  CAS  Google Scholar 

Altmayer V, Ziveri J, Frère C, Salem J-E, Weiss N, Cao A, et al. Endothelial cell biomarkers in critically ill COVID-19 patients with encephalitis. J Neurochem. 2022;161:492–505.

Article  CAS  PubMed  Google Scholar 

Shimohata T. Neuro-COVID-19. Clin Exp Neuroimmunol. 2022;13:17–23.

Article  CAS  PubMed  Google Scholar 

Ahmad SJ, Feigen CM, Vazquez JP, Kobets AJ, Altschul DJ. Neurological sequelae of COVID-19. J Integr Neurosci. 2022;21:77.

Article  PubMed  Google Scholar 

Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP, et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595:565–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif